Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses. The company aims to invent, test, and deliver recombinant therapeutic proteins to treat diseases affecting vulnerable patients.
|HQ||San Diego, CA, US||Map|
|Employees (est.) (Jul 2021)||27||(-3%)|
Ansun BioPharma total Funding
Ansun BioPharma latest funding size
Time since last funding
|2 years ago|
Ansun BioPharma investors
|Matrix Partners China, Korea Investment Partners, Viventures, YuanMing Capital, 3E Bioventures, Junson Capital, Lilly Asia Ventures, SinoPharm Capital, Oceanpine Capital, LYFE Capital, Joincap Investment|
When was Ansun BioPharma founded?
Ansun BioPharma was founded in 2003.
Who are Ansun BioPharma key executives?
Ansun BioPharma's key executives are Nancy Chang, George Wang and Yining Zhao.
How many employees does Ansun BioPharma have?
Ansun BioPharma has 27 employees.
Who are Ansun BioPharma competitors?
Competitors of Ansun BioPharma include Abiogen Pharma, PlasmaGen Biosciences and Alexion Pharmaceuticals.
Where is Ansun BioPharma headquarters?
Ansun BioPharma headquarters is located at 3030 Callan Rd, San Diego.
Where are Ansun BioPharma offices?
Ansun BioPharma has an office in San Diego.
How many offices does Ansun BioPharma have?
Ansun BioPharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies